LABEL Act Linking Abortion-drug Batches for Enforcement and Liability Act
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This bill requires abortion-inducing drugs to display labels with dispenser and prescriber information, creating a tracking and accountability system for these medications.
Why it matters: While focused on drug labeling rather than core pro-life policy, this measure affects the availability and regulatory framework around abortion drugs, a matter of deep concern to many Christian families seeking to protect unborn life.
Topic: Sanctity of life · classifier confidence 72%
What this changes
Amends existing law
Law today: The Federal Food, Drug, and Cosmetic Act currently regulates the labeling and packaging of drugs, including mifepristone and other abortion-inducing medications, but does not require labels to identify the dispenser or prescriber by name and address.
If passed: If this bill became law, abortion-inducing drugs would be required to bear labels listing the name and address of the pharmacy or facility that dispensed them and the name of the prescribing physician. This would create a trackable record linking each dose to the specific dispenser and doctor.
AI-generated from the bill text — verify against the official text.
Likely supporters & opponents
Likely support
- pro-life advocacy groups — Such labeling would enable tracing of abortion drugs to specific providers, potentially supporting enforcement efforts and litigation against abortion providers.
- parental-rights advocates — Detailed labeling could help parents identify where their minor children obtained abortion-inducing drugs and by which physician.
Likely opposition
- abortion-access advocates — Labeling requirements would effectively identify and expose patients and providers to harassment, legal liability, and violence.
- medical and pharmacy associations — Singling out abortion drugs for unique labeling requirements imposes burdens not applied to other medications and complicates pharmaceutical operations.
- privacy-rights organizations — Extensive identifying information on drug packaging violates patient privacy and could be misused for surveillance or prosecution.
AI-inferred typical positions based on the bill’s substance — general stakeholder categories, not confirmed endorsements.
Should I support this?
Likely helpful for Christian families
From a Christian parental-authority perspective, this bill creates transparency and accountability regarding abortion drugs, enabling parents to track their minor children's access to such medications and to know which providers are involved—aligning with values of parental oversight and protection of the unborn. However, supporters of abortion access will view it as a harmful targeting of one medical service for unique scrutiny.
An AI assessment from a Christian-family perspective — religious freedom, parental rights, and freedom in education — not legal or voting advice.
Official summary
To amend the Federal Food, Drug, and Cosmetic Act to ensure that abortion-inducing drugs bear a label identifying the name and address of the dispenser and the name of the prescriber, and for other purposes.
Sponsors
- Barry Moore (R)
- Harriet Hageman (R)
- Mary Miller (R)
- John McGuire (R)
- Andy Harris (R)
- Gary Palmer (R)
- Andrew Clyde (R)
- August Pfluger (R)
- Mark Harris (R)
- Mike Bost (R)
- Tim Burchett (R)
- Pat Harrigan (R)
- Greg Steube (R)
- Michael Guest (R)
- Ron Estes (R)
- Sheri Biggs (R)
Status timeline
- 2025-11-07Referred to the House Committee on Energy and Commerce.H
- 2025-11-07Introduced in HouseH
H = House · S = Senate · A = Assembly